Position in AZN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$379,907,840
New position
Shares Held
1,926,315
first reported quarter
Ownership
0.124%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 98.14739541559922.ToString("F0")%
Shared 0.ToString("F0")%
None 1.852604584400786.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026BANK OF MONTREAL /CAN/ holds $5,682,625,272 across 16 Drug Manufacturers - General names. AZN ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,507,369 | $1,386,432,781 | |
| 2 | JNJ |
Johnson & Johnson
|
4,514,106 | $1,103,428,067 | |
| 3 | ABBV |
AbbVie Inc.
|
3,078,495 | $669,541,874 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,831,161 | $581,140,353 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,549,224 | $494,655,344 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
1,926,315 | $379,907,840 | |
| 7 | AMGN |
Amgen Inc
|
961,165 | $338,185,902 | |
| 8 | GSK |
GSK plc
|
4,639,799 | $256,070,504 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $379,907,840 | 1,926,315 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||